United States Biotechnology & Medical Research

Calithera Biosciences Inc (CALA)

Track

Ticker: CALA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.0
PAKIANATHAN DEEPIKA Non-Executive Director
Transaction date
Sale
Price
173.18
Quantity 14,344 -14.1%
Value US$2,322,813
4.0
PAKIANATHAN DEEPIKA Non-Executive Director
Transaction date
Sale
Price
383.51
Quantity 21,878 +25.6%
Value US$3,945,611
Orford Keith Director Officer
Transaction date
Sale
Price
430.53
Quantity 17,863 -14.5%
Value US$2,668,115
Orford Keith Director Officer
Transaction date
Sale
Price
0.86
Quantity 30,000 -20.8%
Value US$25,695
2.8
DRACHMAN JONATHAN G Non-Executive Director
Transaction date
Purchase
Price
0.86
Quantity 200,000 +inf%
Value US$171,900
Molineaux Christopher SR. VP, DEVELOPMENT Officer
Transaction date
Purchase
Price
0.85
Quantity 100,000 +21.9%
Value US$84,670
Molineaux Susan PRESIDENT & CEO Executive Director
Transaction date
Purchase
Price
0.85
Quantity 100,000 +21.9%
Value US$84,670
Orford Keith Non-Executive Director
Transaction date
Sale
Price
0.84
Quantity 51,810 -26.4%
Value US$43,520
Orford Keith Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.00
Quantity 2,447 -18.1%
Value US$14,682
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
6.00
Quantity 192,250 -28.6%
Value US$1,153,500
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
6.00
Quantity 1,064,332 -27.8%
Value US$6,385,992
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Sale
Price
6.00
Quantity 1,027,016 -21.7%
Value US$6,162,096
Wong Stephanie SR. VP, FINANCE & SECRETARY Officer
Transaction date
Planned sale
Price
8.00
Quantity 5,000 -14.3%
Value US$40,000
Orford Keith Chief Medical Officer Officer
Transaction date
Planned sale
Price
8.00
Quantity 3,021 -26.1%
Value US$24,168
Orford Keith Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.00
Quantity 3,021 -20.7%
Value US$18,126
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
3.91
Quantity 14,151 +2.1%
Value US$55,353
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
3.91
Quantity 79,285 +2.1%
Value US$310,131
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
3.91
Quantity 98,518 +2.1%
Value US$385,363
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
3.37
Quantity 11,105 +1.7%
Value US$37,424
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
3.37
Quantity 45,888 +1.2%
Value US$154,643
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
3.37
Quantity 71,495 +1.6%
Value US$240,938
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
2.70
Quantity 57,868 +9.8%
Value US$156,244
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
2.70
Quantity 331,048 +9.8%
Value US$893,830
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
2.70
Quantity 408,592 +9.8%
Value US$1,103,198
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
2.60
Quantity 116,552 +24.6%
Value US$303,035
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
2.60
Quantity 610,052 +22.1%
Value US$1,586,135
4.0
BVF PARTNERS L P/IL Large shareholder
Transaction date
Purchase
Price
2.60
Quantity 872,373 +26.5%
Value US$2,268,170
Molineaux Christopher SR. VP, DEVELOPMENT
Transaction date
Planned purchase
Price
3.88
Quantity 51,600 +12.7%
Value US$200,208
Molineaux Susan PRESIDENT AND CEO Executive Director
Transaction date
Planned purchase
Price
3.88
Quantity 51,600 +12.7%
Value US$200,208
Orford Keith Chief Medical Officer
Transaction date
Planned sale
Price
6.00
Quantity 417 -3.3%
Value US$2,502
Orford Keith Chief Medical Officer
Transaction date
Planned sale
Price
6.00
Quantity 416 -4.0%
Value US$2,496
Orford Keith Chief Medical Officer
Transaction date
Planned sale
Price
6.33
Quantity 416 -3.8%
Value US$2,633
Orford Keith Chief Medical Officer
Transaction date
Planned sale
Price
6.43
Quantity 417 -3.7%
Value US$2,681
Orford Keith Chief Medical Officer Officer
Transaction date
Planned sale
Price
6.00
Quantity 1,565 -12.2%
Value US$9,390
Orford Keith SR. VP, CLINICAL DEVELOPMENT Officer
Transaction date
Planned sale
Price
6.05
Quantity 313 -2.9%
Value US$1,894
Orford Keith SR. VP, CLINICAL DEVELOPMENT Officer
Transaction date
Planned sale
Price
6.00
Quantity 1,252 -10.5%
Value US$7,512
ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
Transaction date
Sale
Price
15.50
Quantity 38,000 -1.1%
Value US$589,000
ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
Transaction date
Sale
Price
15.59
Quantity 186,000 -4.9%
Value US$2,899,740
ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
Transaction date
Sale
Price
15.68
Quantity 352,000 -8.5%
Value US$5,519,360
Wong Stephanie VP, FINANCE AND SECRETARY Officer
Transaction date
Planned sale
Price
18.41
Quantity 3,552 -25.2%
Value US$65,385
Orford Keith SR. VP, CLINICAL DEVELOPMENT Officer
Transaction date
Planned sale
Price
18.31
Quantity 2,120 -23.6%
Value US$38,823
Hecht Curtis SVP, BUS. & CORP. DEVELOPMENT Officer
Transaction date
Planned sale
Price
18.00
Quantity 700 -4.2%
Value US$12,600
Hecht Curtis SVP, BUS. & CORP. DEVELOPMENT Officer
Transaction date
Planned sale
Price
16.00
Quantity 650 -4.2%
Value US$10,400
ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
Transaction date
Purchase
Price
10.25
Quantity 487,804 +13.4%
Value US$4,999,991
Hecht Curtis SVP, BUS. & CORP. DEVELOPMENT
Transaction date
Planned sale
Price
14.00
Quantity 600 -3.7%
Value US$8,400
Hecht Curtis See Remarks
Transaction date
Planned sale
Price
12.00
Quantity 550 -3.3%
Value US$6,600
ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
Transaction date
Purchase
Price
3.15
Quantity 500,000 +15.9%
Value US$1,575,000
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
6.07
Quantity 40,168 +1.3%
Value US$243,768
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 41,800 +1.4%
Value US$250,938
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 25,000 +0.8%
Value US$149,942
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.95
Quantity 2,300 +0.1%
Value US$13,685
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.93
Quantity 88,000 +3.0%
Value US$521,840
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.58
Quantity 22,000 +0.8%
Value US$122,760
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.55
Quantity 20,700 +0.7%
Value US$114,885
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.35
Quantity 32,400 +1.1%
Value US$173,340
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.17
Quantity 29,089 +1.0%
Value US$150,390
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.58
Quantity 19,578 +0.7%
Value US$109,245
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.43
Quantity 6,253 +0.2%
Value US$33,954
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
5.41
Quantity 9,848 +0.4%
Value US$53,278
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
4.65
Quantity 32,058 +1.2%
Value US$149,070
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
4.70
Quantity 200 +0.0%
Value US$940
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
6.80
Quantity 25,000 +0.9%
Value US$170,000
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
7.25
Quantity 13,000 +0.5%
Value US$94,250
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
6.99
Quantity 25,000 +0.9%
Value US$174,750
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 30,000 +1.1%
Value US$210,000
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
6.94
Quantity 88,700 +3.4%
Value US$615,578
Delphi Management Partners VIII, L.L.C. Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 4,835 +26.0%
Value US$48,350
Delphi Management Partners VIII, L.L.C. Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 495,165 +26.0%
Value US$4,951,650
George Jean Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 300,000 +16.6%
Value US$3,000,000
MORGENTHALER VENTURE PARTNERS IX LP Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 350,000 +19.3%
Value US$3,500,000
Christoffersen Ralph E Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 350,000 +19.3%
Value US$3,500,000
Advanced Technology Ventures VIII LP Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 300,000 +16.6%
Value US$3,000,000
PAKIANATHAN DEEPIKA Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 4,835 +26.0%
Value US$48,350
PAKIANATHAN DEEPIKA Non-Executive Director Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 495,165 +26.0%
Value US$4,951,650
ADAGE CAPITAL PARTNERS GP LLC Large shareholder
Transaction date
Purchase
Price
10.00
Quantity 800,000 +44.9%
Value US$8,000,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-31 2023-01-27 S Sale
4.0
PAKIANATHAN DEEPIKA
Non-Executive Director
14,344 -14.1%
173.18
US$2,322,813 		14,344 -14.1% 173.18 US$2,322,813
2023-01-31 2023-01-27 S Sale
4.0
PAKIANATHAN DEEPIKA
Non-Executive Director
21,878 +25.6%
383.51
US$3,945,611 		21,878 +25.6% 383.51 US$3,945,611
2021-11-12 2021-11-11 S Sale
Orford Keith

Director

Officer
17,863 -14.5%
430.53
US$2,668,115 		17,863 -14.5% 430.53 US$2,668,115
2021-11-12 2021-11-10 S Sale
Orford Keith

Director

Officer
30,000 -20.8%
0.86
US$25,695 		30,000 -20.8% 0.86 US$25,695
2021-11-10 2021-11-10 B Purchase
2.8
DRACHMAN JONATHAN G
Non-Executive Director
200,000 +inf%
0.86
US$171,900 		200,000 +inf% 0.86 US$171,900
2021-11-10 2021-11-10 B Purchase
Molineaux Christopher

SR. VP, DEVELOPMENT

Officer
100,000 +21.9%
0.85
US$84,670 		100,000 +21.9% 0.85 US$84,670
2021-11-10 2021-11-10 B Purchase
Molineaux Susan

PRESIDENT & CEO

Executive Director
100,000 +21.9%
0.85
US$84,670 		100,000 +21.9% 0.85 US$84,670
2021-11-09 2021-11-09 S Sale
Orford Keith
Non-Executive Director
51,810 -26.4%
0.84
US$43,520 		51,810 -26.4% 0.84 US$43,520
2020-12-18 2020-12-16 PlS Planned sale
Orford Keith

Chief Medical Officer

Officer
2,447 -18.1%
6.00
US$14,682 		2,447 -18.1% 6.00 US$14,682
2020-05-26 2020-05-21 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
192,250 -28.6%
6.00
US$1,153,500 		192,250 -28.6% 6.00 US$1,153,500
2020-05-26 2020-05-21 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
1,064,332 -27.8%
6.00
US$6,385,992 		1,064,332 -27.8% 6.00 US$6,385,992
2020-05-26 2020-05-21 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
1,027,016 -21.7%
6.00
US$6,162,096 		1,027,016 -21.7% 6.00 US$6,162,096
2020-04-17 2020-04-15 PlS Planned sale
Wong Stephanie

SR. VP, FINANCE & SECRETARY

Officer
5,000 -14.3%
8.00
US$40,000 		5,000 -14.3% 8.00 US$40,000
2020-02-24 2020-02-20 PlS Planned sale
Orford Keith

Chief Medical Officer

Officer
3,021 -26.1%
8.00
US$24,168 		3,021 -26.1% 8.00 US$24,168
2019-12-26 2019-12-23 PlS Planned sale Orford Keith

Chief Medical Officer

Officer
3,021 -20.7%
6.00
US$18,126 		3,021 -20.7% 6.00 US$18,126
2019-11-22 2019-11-20 B Purchase BVF PARTNERS L P/IL Large shareholder
14,151 +2.1%
3.91
US$55,353 		14,151 +2.1% 3.91 US$55,353
2019-11-22 2019-11-20 B Purchase BVF PARTNERS L P/IL Large shareholder
79,285 +2.1%
3.91
US$310,131 		79,285 +2.1% 3.91 US$310,131
2019-11-22 2019-11-20 B Purchase BVF PARTNERS L P/IL Large shareholder
98,518 +2.1%
3.91
US$385,363 		98,518 +2.1% 3.91 US$385,363
2019-11-18 2019-11-14 B Purchase BVF PARTNERS L P/IL Large shareholder
11,105 +1.7%
3.37
US$37,424 		11,105 +1.7% 3.37 US$37,424
2019-11-18 2019-11-14 B Purchase BVF PARTNERS L P/IL Large shareholder
45,888 +1.2%
3.37
US$154,643 		45,888 +1.2% 3.37 US$154,643
2019-11-18 2019-11-14 B Purchase BVF PARTNERS L P/IL Large shareholder
71,495 +1.6%
3.37
US$240,938 		71,495 +1.6% 3.37 US$240,938
2019-10-31 2019-10-30 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
57,868 +9.8%
2.70
US$156,244 		57,868 +9.8% 2.70 US$156,244
2019-10-31 2019-10-30 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
331,048 +9.8%
2.70
US$893,830 		331,048 +9.8% 2.70 US$893,830
2019-10-31 2019-10-30 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
408,592 +9.8%
2.70
US$1,103,198 		408,592 +9.8% 2.70 US$1,103,198
2019-10-31 2019-10-29 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
116,552 +24.6%
2.60
US$303,035 		116,552 +24.6% 2.60 US$303,035
2019-10-31 2019-10-29 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
610,052 +22.1%
2.60
US$1,586,135 		610,052 +22.1% 2.60 US$1,586,135
2019-10-31 2019-10-29 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
872,373 +26.5%
2.60
US$2,268,170 		872,373 +26.5% 2.60 US$2,268,170
2019-06-27 2019-06-25 PP Planned purchase
Molineaux Christopher

SR. VP, DEVELOPMENT
51,600 +12.7%
3.88
US$200,208 		51,600 +12.7% 3.88 US$200,208
2019-06-27 2019-06-25 PP Planned purchase
Molineaux Susan

PRESIDENT AND CEO

Executive Director
51,600 +12.7%
3.88
US$200,208 		51,600 +12.7% 3.88 US$200,208
2019-06-19 2019-06-17 PlS Planned sale
Orford Keith

Chief Medical Officer
417 -3.3%
6.00
US$2,502 		417 -3.3% 6.00 US$2,502
2019-05-24 2019-05-22 PlS Planned sale
Orford Keith

Chief Medical Officer
416 -4.0%
6.00
US$2,496 		416 -4.0% 6.00 US$2,496
2019-04-17 2019-04-15 PlS Planned sale
Orford Keith

Chief Medical Officer
416 -3.8%
6.33
US$2,633 		416 -3.8% 6.33 US$2,633
2019-03-19 2019-03-15 PlS Planned sale
Orford Keith

Chief Medical Officer
417 -3.7%
6.43
US$2,681 		417 -3.7% 6.43 US$2,681
2019-03-13 2019-03-11 PlS Planned sale
Orford Keith

Chief Medical Officer

Officer
1,565 -12.2%
6.00
US$9,390 		1,565 -12.2% 6.00 US$9,390
2018-10-17 2018-10-15 PlS Planned sale Orford Keith

SR. VP, CLINICAL DEVELOPMENT

Officer
313 -2.9%
6.05
US$1,894 		313 -2.9% 6.05 US$1,894
2018-10-15 2018-10-11 PlS Planned sale Orford Keith

SR. VP, CLINICAL DEVELOPMENT

Officer
1,252 -10.5%
6.00
US$7,512 		1,252 -10.5% 6.00 US$7,512
2017-09-28 2017-09-28 S Sale ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
38,000 -1.1%
15.50
US$589,000 		38,000 -1.1% 15.50 US$589,000
2017-09-28 2017-09-27 S Sale ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
186,000 -4.9%
15.59
US$2,899,740 		186,000 -4.9% 15.59 US$2,899,740
2017-09-28 2017-09-26 S Sale ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
352,000 -8.5%
15.68
US$5,519,360 		352,000 -8.5% 15.68 US$5,519,360
2017-07-19 2017-07-17 PlS Planned sale Wong Stephanie

VP, FINANCE AND SECRETARY

Officer
3,552 -25.2%
18.41
US$65,385 		3,552 -25.2% 18.41 US$65,385
2017-07-19 2017-07-17 PlS Planned sale Orford Keith

SR. VP, CLINICAL DEVELOPMENT

Officer
2,120 -23.6%
18.31
US$38,823 		2,120 -23.6% 18.31 US$38,823
2017-07-07 2017-07-06 PlS Planned sale Hecht Curtis

SVP, BUS. & CORP. DEVELOPMENT

Officer
700 -4.2%
18.00
US$12,600 		700 -4.2% 18.00 US$12,600
2017-05-23 2017-05-19 PlS Planned sale Hecht Curtis

SVP, BUS. & CORP. DEVELOPMENT

Officer
650 -4.2%
16.00
US$10,400 		650 -4.2% 16.00 US$10,400
2017-03-24 2017-03-22 B Purchase ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
487,804 +13.4%
10.25
US$4,999,991 		487,804 +13.4% 10.25 US$4,999,991
2017-03-15 2017-03-13 PlS Planned sale Hecht Curtis

SVP, BUS. & CORP. DEVELOPMENT
600 -3.7%
14.00
US$8,400 		600 -3.7% 14.00 US$8,400
2017-03-06 2017-03-02 PlS Planned sale Hecht Curtis

See Remarks
550 -3.3%
12.00
US$6,600 		550 -3.3% 12.00 US$6,600
2016-11-17 2016-11-16 B Purchase ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
500,000 +15.9%
3.15
US$1,575,000 		500,000 +15.9% 3.15 US$1,575,000
2015-09-24 2015-09-23 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
40,168 +1.3%
6.07
US$243,768 		40,168 +1.3% 6.07 US$243,768
2015-09-24 2015-09-22 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
41,800 +1.4%
6.00
US$250,938 		41,800 +1.4% 6.00 US$250,938
2015-09-24 2015-09-22 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,000 +0.8%
6.00
US$149,942 		25,000 +0.8% 6.00 US$149,942
2015-09-08 2015-09-04 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
2,300 +0.1%
5.95
US$13,685 		2,300 +0.1% 5.95 US$13,685
2015-09-08 2015-09-03 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
88,000 +3.0%
5.93
US$521,840 		88,000 +3.0% 5.93 US$521,840
2015-08-28 2015-08-28 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
22,000 +0.8%
5.58
US$122,760 		22,000 +0.8% 5.58 US$122,760
2015-08-28 2015-08-28 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
20,700 +0.7%
5.55
US$114,885 		20,700 +0.7% 5.55 US$114,885
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
32,400 +1.1%
5.35
US$173,340 		32,400 +1.1% 5.35 US$173,340
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
29,089 +1.0%
5.17
US$150,390 		29,089 +1.0% 5.17 US$150,390
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
19,578 +0.7%
5.58
US$109,245 		19,578 +0.7% 5.58 US$109,245
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
6,253 +0.2%
5.43
US$33,954 		6,253 +0.2% 5.43 US$33,954
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
9,848 +0.4%
5.41
US$53,278 		9,848 +0.4% 5.41 US$53,278
2015-08-28 2015-08-26 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
32,058 +1.2%
4.65
US$149,070 		32,058 +1.2% 4.65 US$149,070
2015-08-28 2015-08-26 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
200 +0.0%
4.70
US$940 		200 +0.0% 4.70 US$940
2014-10-15 2014-10-15 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,000 +0.9%
6.80
US$170,000 		25,000 +0.9% 6.80 US$170,000
2014-10-15 2014-10-15 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
13,000 +0.5%
7.25
US$94,250 		13,000 +0.5% 7.25 US$94,250
2014-10-15 2014-10-14 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,000 +0.9%
6.99
US$174,750 		25,000 +0.9% 6.99 US$174,750
2014-10-15 2014-10-14 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
30,000 +1.1%
7.00
US$210,000 		30,000 +1.1% 7.00 US$210,000
2014-10-15 2014-10-13 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
88,700 +3.4%
6.94
US$615,578 		88,700 +3.4% 6.94 US$615,578
2014-10-09 2014-10-07 B Purchase Delphi Management Partners VIII, L.L.C. Large shareholder
4,835 +26.0%
10.00
US$48,350 		4,835 +26.0% 10.00 US$48,350
2014-10-09 2014-10-07 B Purchase Delphi Management Partners VIII, L.L.C. Large shareholder
495,165 +26.0%
10.00
US$4,951,650 		495,165 +26.0% 10.00 US$4,951,650
2014-10-09 2014-10-07 B Purchase George Jean Non-Executive Director Large shareholder
300,000 +16.6%
10.00
US$3,000,000 		300,000 +16.6% 10.00 US$3,000,000
2014-10-09 2014-10-07 B Purchase MORGENTHALER VENTURE PARTNERS IX LP Large shareholder
350,000 +19.3%
10.00
US$3,500,000 		350,000 +19.3% 10.00 US$3,500,000
2014-10-09 2014-10-07 B Purchase Christoffersen Ralph E Non-Executive Director Large shareholder
350,000 +19.3%
10.00
US$3,500,000 		350,000 +19.3% 10.00 US$3,500,000
2014-10-09 2014-10-07 B Purchase Advanced Technology Ventures VIII LP Large shareholder
300,000 +16.6%
10.00
US$3,000,000 		300,000 +16.6% 10.00 US$3,000,000
2014-10-09 2014-10-07 B Purchase PAKIANATHAN DEEPIKA Non-Executive Director Large shareholder
4,835 +26.0%
10.00
US$48,350 		4,835 +26.0% 10.00 US$48,350
2014-10-09 2014-10-07 B Purchase PAKIANATHAN DEEPIKA Non-Executive Director Large shareholder
495,165 +26.0%
10.00
US$4,951,650 		495,165 +26.0% 10.00 US$4,951,650
2014-10-03 2014-10-01 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
800,000 +44.9%
10.00
US$8,000,000 		800,000 +44.9% 10.00 US$8,000,000
Explore more

More insider trading research around Calithera Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America